A Phase 2 trial is the second stage of clinical research in drug development, following Phase 1 safety testing. It involves a larger group of participants to evaluate the treatment’s effectiveness, optimal dosing, and potential side effects. These trials are critical for determining whether a drug should proceed to Phase 3, where broader testing occurs, and are closely monitored by regulators and investors due to their impact on pharmaceutical approval timelines.